Treatment with ABBV-2222, an investigational CFTR corrector formerly known as GLPG2222, was well-tolerated and partially corrected the function…
Articles by Joana Carvalho, PhD
AzurRx BioPharma has reached its patient enrollment goal in the ongoing Phase 2 trial testing the effectiveness of MS1819-SD,…
Abeona Therapeutics‘ new gene therapy ABO-401 for the treatment of cystic fibrosis (CF) has successfully delivered a functional version of…
Motif Bio has entered an agreement with Lamellar Biomedical to undertake a preclinical study that will test a new…
Students with cystic fibrosis have the opportunity to apply for up to $25,000 in scholarships under the AbbVie CF Scholarship…
People with cystic fibrosis (CF) who have been infected by cytomegalovirus (CMV) are more likely to experience faster disease progression…
Choline supplementation improves lung function and liver health in people with cystic fibrosis (CF), and should be considered as…
Despite being commonly found in patients with cystic fibrosis-related diabetes, the bacteria Stenotrophomonas maltophilia cannot be considered as an independent…
The nutritional status of cystic fibrosis (CF) patients after a lung transplant — as assessed by body composition — is…